Diseases, Conditions, Syndromes

Diabetes drug slows kidney function decline

Clinical trial data reveal that dapagliflozin— a sodium-glucose cotransporter 2 inhibitor prescribed to treat diabetes—reduces the rate of kidney function decline in patients with chronic kidney disease (CKD). The findings ...

page 9 from 37